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 Introduction 
 Eating disorders (EDs) represent a common and seri-
ous class of psychiatric disorders. According to DSM-IV 
 [1] , they include anorexia nervosa (AN), bulimia ner-
vosa (BN), binge eating disorder and EDs not otherwise 
specified (EDNOS). Psychological EDs are an increasing 
public health problem  [2] with severe clinical manifesta-
tions: hypothermia, hypotension, electrolyte imbalance, 
endocrine disorders and kidney failure. AN is character-
ized by a severely calorie-restricted diet, resulting in a 
body weight that is at least 85% below that expected for 
age and height. BN is identified by frequent fluctuations 
in weight and recurrent episodes of compulsive bingeing 
followed by self-induced vomiting, purging, fasting, lax-
ative use and/or excessive exercise in attempts to avoid 
weight gain. Binge eating disorder is a more recently de-
scribed syndrome characterized by repeated episodes of 
binge eating, similar to those of BN, in the absence of 
inappropriate compensatory behavior. EDNOS include 
behaviors such as chronic dieting, purging and binge 
eating, which do not meet the full criteria for a specific 
eating disorder; they are two to five times as common as 
the clinical EDs  [3] . The correlation between kidney dis-
ease and EDs is of interest in common nephrological 
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 Abstract 
 Psychological eating disorders – anorexia nervosa (AN), bu-
limia nervosa (BN), binge eating disorder – are an increasing 
public health problem with severe clinical manifestations: 
hypothermia, hypotension, electrolyte imbalance, endo-
crine disorders and kidney failure; they are of interest to ne-
phrologists, but pathophysiological mechanisms in deter-
mining the renal involvement are still unclear. We describe 
pathophysiology, histological features and clinical manifes-
tations of the most frequent psychological eating disorders: 
AN and BN. Regarding AN, we analyze the recent literature, 
and identify 3 principal pathways towards renal involve-
ment: chronic dehydration-hypokalemia, nephrocalcinosis 
and chronic rhabdomyolysis. Regarding BN, we describe the 
correlation between obesity and many proinflammatory cy-
tokines, chemokines, growth factors and adipokines, having 
potential metabolic and hemodynamic effects on the kid-
ney and an important role in the pathogenesis of obesity-
related renal injury, independently of hypertension and dia-
betes.  Copyright © 2011 S. Karger AG, Basel 
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practice, but pathophysiological mechanisms in deter-
mining the renal involvement are still unclear. Some-
times, it is difficult to determine renal excretory func-
tion in this population: in 55 patients with AN and 44 
patients with BN, Fabbian et al. [4] evaluated renal func-
tion with Cockcroft-Gault (C-G) formula for creatinine 
clearance calculation and glomerular filtration rate 
(GFR) with MAYO and MDRD equations. They deter-
mined that C-G is inaccurate when it is applied to obese 
or cachectic subjects, MDRD underestimates renal 
function in normal-high GFR, and MAYO seems to be 
a good alternative to the other equations leading to cor-
rect classification of patients.
 About the chronic kidney failure, in 1985 Boag et al. 
[5] showed an improvement in creatinine clearance with 
weight gain in 9 of 10 patients with AN. There are no fur-
ther studies in the literature about the evolution of renal 
function impairment in AN. We describe pathophysiol-
ogy, histological features and clinical manifestations of 
the most frequent psychological EDs: AN and BN.
 Discussion 
 Anorexia Nervosa 
 Hypokalemia is the most common laboratory find-
ing in AN. Miller et al. [6] detected a prevalence of 19.7% 
of hypokalemia among 214 women with AN. Hypokale-
mic nephropathy is a well-known disease  [7] character-
ized by renal hypertrophy and renal tubular cell hyper-
plasia involving the medullary collecting ducts and, to 
a lesser extent, the thick ascending limb in association 
with tubular atrophy, interstitial macrophage infiltra-
tion and interstitial fibrosis. Analyzing the most recent 
literature, we identify 3 principal pathways towards re-
nal involvement: chronic dehydration and hypokale-
mia, nephrocalcinosis and chronic rhabdomyolysis 
( fig. 1 ). Chronic potassium depletion could lead to irre-
versible damage to the renal tubule. In vitro studies in 
rat models demonstrated a progressive hypokalemia-in-
duced tubulointerstitial injury. The number of patients 
with AN who underwent histological evaluation is lim-
ited. Arimura et al.  [8] highlighted in well-documented 
histological reports of AN chronic tubulointerstitial ne-
phritis with prolonged hypoka lemia. Manzato et al. [9] 
suggested a possible type of hypokalemic nephritis spe-
cific to AN and characterized by tubular atrophy, mono-
nucleocyte infiltration into the interstitial spaces, inter-
stitial fibrosis and juxtaglomerular hyperplasia. Loss of 
water and salts (diuretic and laxative abuse), metabolic 
alkalosis (loss of acids through vomiting) and hyperal-
dosteronism secondary to hypovolemia in AN induced 
hypokalemia and chronic dehydration. It is possible to 
misdiagnose an eating disorder as a primary tubulopa-
thy (e.g. Gitelman’s disease) and vice versa. Three patho-
physiological mechanisms may lead to renal lesions: in-
creased ammoniogenesis, activation of vasoactive me-
diators and arterial hypersensitivity to Na + . Hypokalemia 
stimulates HCO3– reabsorption and ammoniogenesis 
followed by amination of C3, with consequent activa-
tion of the alternative complement pathway and deposi-
tion of proteins in the tubule. Hypokalemia causes al-
terations in the levels of vasoactive mediators: increase 
in vasoconstrictor stimuli (ACE, ET-1 and subtype B   -
adrenergic receptors) and reduction in vasodilatory 
stimuli (EDRF-1 and PGE2). Moreover, hypokalemia is 
associated with increased activity of the cotransporter 
Na + K + 2Cl – in the ascending limb of the loop of Henle; it 
may be consequent to hydrosaline retention and some-
times elevated arterial pressure. Nephrolithiasis and 
electrolyte disturbances (hypokalemia, hyponatremia, 
hypocalcemia, hypomagnesemia and hypophosphate-
mia) have been reported in patients with AN; they are 
potential risk factors that may predispose to nephrocal-
cinosis. Chronic diarrhea may also contribute to neph-
rocalcinosis by causing chronic volume depletion. Renal 
failure may result from tubular cell injury, tubular ob-
struction by calcified debris, and atrophy of nephrons. 
Chronic inflammation and interstitial fibrosis accom-
pany these changes. Roberts et al. [10] described 2 cases 












 Fig. 1. Principal pathways towards renal involvement. 
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logical findings, and Lim et al. [11] reported 1 case of 
nephrocalcinosis and senna misuse, both in anorexic 
patients. Hypokalemia is a known cause of rhabdomy-
olysis. There are some case reports of rhabdomyolysis in 
AN with  [12] or without  [13] acute renal failure. We sup-
pose that dietary restriction and starvation, severe ener-
getic deficit, chronic dehydration and metabolic de-
rangement, especially hypophosphatemia and/or phos-
phate depletion, may induce chronic subclinical release 
of tissue catabolism products (CK, aldolase, AST, ALT, 
LDH, myoglobin) and chronic kidney injury. In AN pa-
tients, a significant alteration of the osmoregulation has 
been documented with an impaired urinary concentrat-
ing ability and a blunted reactivity of ADH. The poten-
tial influence of antidepressant drugs has been suggest-
ed  [14] . This alteration may contribute to hydroelectro-
lytic imbalance and chronic renal failure. 
 Bulimia Nervosa 
 Renal function has been reported to be impaired even 
in the short-term by binge/purges in bulimia  [15] . How-
ever, few studies have examined the extent of renal dam-
age, especially morphologic changes, over long-term bu-
limic symptoms  [16, 17] . Yasuhara et al. [17] described a 
case of a woman with longstanding BN and end-stage re-
nal disease (ESRD). After the patient died of pneumonia 
and sepsis at age 52 years, autopsy of her kidney showed 
chronic interstitial nephritis and proximal tubular swell-
ing. These morphologic changes were consistent with hy-
pokalemic nephropathy. Moreover, autopsy examination 
of the kidneys revealed diffuse glomerular sclerosis, 
which may be also induced by obesity during the period 
of increased body weight. Indeed, a positive association 
between high body mass index (BMI) and risk for chron-
ic kidney disease has been reported  [17, 18] . In a large 
study performed in 320,252 adult volunteers, the adjusted 
relative risk for ESRD was 3.6 (95% CI, 3.05–4.18) for 
those with class I obesity (BMI, 30.0–34.9), 6.1 (95% CI, 
5.0–7.5) for those with class II obesity (BMI, 35.0–39.9) 
and 7.1 (95% CI, 5.4–9.30) for those with morbid obesity 
(BMI  6 40) compared with persons who had normal 
weight (BMI, 18.5–24.9)  [16] .
 This finding persisted even after additional adjust-
ments for baseline blood pressure level and presence or 
absence of diabetes mellitus  [18] .
 Obesity 
 There are two major mechanisms by which obesity 
causes chronic kidney disease: (1) obesity may cause kid-
ney damage directly or (2) through obesity-associated 
diseases. There are several studies showing how obesity 
may result in functional and structural changes in the 
kidney. Morphologic features in obese individuals in-
clude glomerulomegaly, focal segmental glomeruloscle-
rosis with predominance of classic perihilar lesions of 
sclerosis, and relatively mild foot process fusion (obesity-
related glomerulopathy). Severe obesity is characterized 
by an increase in GFR, renal plasma flow, albumin excre-
tion rate and fractional albumin clearance. Early stages 
of obesity in animal models result in increase in arterial 
pressure, hyperinsulinemia, activation of the renin-
angiotensin system and glomerular hyperfiltration. 
Hormonal changes, low-grade inflammation, oxidative 
stress and endothelial dysfunction are the main possible 
pathogenic mechanisms of renal damage in obesity. 
During the last decade, white adipose tissue was recog-
nized as an active endocrine organ and a source of many 
proinflammatory cytokines, chemokines, growth fac-
tors (angiotensin II, and transforming growth factor-  1 ), 
complement proteins called ‘adipokines’ or ‘adipocyto-
kines’. These adipokines, having potential metabolic and 
hemodynamic effects on the kidney, seem to play an im-
portant role in the pathogenesis of obesity-related renal 
injury, independently of hypertension and diabetes. Pa-
tients with BN frequently exhibit fluid-electrolyte and 
acid-base disturbances. Routine screening detects an 
electrolyte abnormality in 10% of patients with BN. This 
is attributed to an erratic eating pattern, often accompa-
nied by vomiting, ingestion of laxatives or diuretics, and 
use of enemas, frequently leading to dehydration. Dehy-
dration can cause volume depletion that may contribute, 
even acutely, to impaired renal function. Although renal 
dysfunction in AN is often corrected after weight gain, 
habitual binge/purges in BN tend to be treatment resis-
tant, which could lead to irreversible renal changes. 
Therefore, in patients with BN, intensive monitoring, 
early detection, and adequate treatment of fluid-electro-
lyte abnormalities and of kidney function disturbances 
are very important.
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The review by Li Cavoli et al. on renal manifestations of 
eating disorders reminds nephrologists of a number of 
electrolyte disorders associated with anorexia nervosa, 
including severe hypokalemia, hyponatremia and hypo-
phosphatemia. Severe dehydration and alkalosis can also 
contribute to impaired kidney function as well as ammo-
nium urate stone formation in these individuals. There-
fore, careful scrutiny of fluid intake to regularly monitor 
serum electrolytes is important in the care of people with 
this eating disorder. Formulation of effective and preven-
tive treatments can attenuate the risks of acute kidney 
injury. Anorexia as well as bulimia nervosa has also been 
associated with rhabdomyolysis and its complications. 
Bulimia and obesity may predispose to microalbumin-
uria and focal segmental glomerulosclerosis. Finally, the 
authors stress the difficulties of estimating renal function 
Editorial Comment
M. El Nahas, Sheffield
(glomerular filtration rate, GFR) in people with eating 
disorders and extremes of weight. Cockroft-Gault is in-
accurate when applied to obese or cachectic subjects. 
MDRD underestimates renal function in normal-high 
GFR. The Mayo Clinic quadratic equation seems to be a 
good alternative compared to the other equations leading 
to a correct diagnosis and classification of subjects with 
eating disorders as renal insufficient [1]. Faced with an 
individual with a severe eating disorder, the nephrologist 
should be aware of the range of fluid and electrolyte dis-
orders that can affect the kidneys acutely and chronically. 
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